Nyxoah (NYXH) Cash from Investing Activities (2021 - 2026)
Nyxoah (NYXH) posted quarterly Cash from Investing Activities of $5.4 million for Q1 2026, down 36.97% year-over-year from $8.6 million in Q1 2025, and up 163.64% quarter-over-quarter from -$8.5 million in Q4 2025.
Nyxoah (NYXH) Cash from Investing Activities (2021 - 2026) Analysis & Trends
Nyxoah's Cash from Investing Activities history runs 6 years deep, the most recent figure standing at $5.4 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 36.97% year-over-year to $5.4 million; the TTM figure through Mar 2026 stood at $28.4 million (up 226.24% YoY), while the FY2025 annual figure was $33.0 million, up 289.05% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at $5.4 million, up from -$8.5 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $53.4 million in Q1 2022, with the low at -$106.2 million in Q2 2022.
- The 5-year median for Cash from Investing Activities is $8.0 million (2023), against an average of -$2.2 million.
- Peak annual rise in Cash from Investing Activities reached 2593.7% in 2022, while the deepest fall reached 1501.09% in 2022.
- Nyxoah's Cash from Investing Activities stood at -$59.5 million in 2022, then surged by 137.56% to $22.3 million in 2023, then plunged by 131.46% to -$7.0 million in 2024, then slipped by 20.49% to -$8.5 million in 2025, then surged by 163.64% to $5.4 million in 2026.
- Business Quant data shows NYXH's Cash from Investing Activities at $5.4 million in Q1 2026, -$8.5 million in Q4 2025, and $10.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Nyxoah | 90.94 Mn | 90.94 Mn | 5.33 Mn | -25.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.93 Mn |
| Jun 30, 2026 | -25.93 Mn |
| Mar 31, 2026 | 5.39 Mn |
| Mar 31, 2026 | 5.39 Mn |
| Dec 31, 2025 | -8.47 Mn |
| Dec 31, 2025 | -8.47 Mn |
| Sep 30, 2025 | 10.31 Mn |
| Sep 30, 2025 | 10.31 Mn |
| Jun 30, 2025 | 21.12 Mn |
| Jun 30, 2025 | 21.12 Mn |
| Mar 31, 2025 | 8.55 Mn |
| Mar 31, 2025 | 8.55 Mn |
| Dec 31, 2024 | -7.03 Mn |
| Dec 31, 2024 | -7.03 Mn |
| Sep 30, 2024 | 6.39 Mn |
| Sep 30, 2024 | 6.39 Mn |
| Jun 30, 2024 | -30.37 Mn |
| Jun 30, 2024 | -30.37 Mn |
| Mar 31, 2024 | 13.73 Mn |
| Mar 31, 2024 | 13.73 Mn |